-
Mr. Cai Mengjie, CEO of Huaren pharmaceutical, resigned
Time of Update: 2019-08-01
On July 31, the board of directors of Huaren Pharmaceutical Co., Ltd recently received the resignation application of CAI Mengjie, the company's executive president, according to a notice issued by Hu
-
To squeeze the marketing mode of "sales with gold" from the source
Time of Update: 2018-11-16
From February 2016, the general office of the State Council issued the opinions of the general office of the State Council on the evaluation of the consistency of quality and efficacy of generic drugs
-
[Research Report] life saving straw for lung cancer patients
Time of Update: 2017-08-28
Tagrisso is an irreversible selective EGFR mutation inhibitor, which can act on the activated and resistant EGFR The drug has been approved for use in more than 40 countries and regions, such as the U
-
Retail o2o: how can B2C logistics go up with the wind when the policy is loosened
Time of Update: 2015-01-22
Source: pharmaceutical economic news 2015-01-22, as a special product, has relatively high requirements for logistics conditions The whole logistics fields such as storage, transportation, distributio
-
Pfizer or buy Actavis
Time of Update: 2014-09-04
Source: bioprospecting 2014-09-04 recently, Bloomberg business week, a foreign media, speculated that Pfizer intended to acquire another company, atvis, after its defeat in acquiring AstraZeneca last
-
Forbes: three misunderstandings about biotechnology
Time of Update: 2014-04-03
Source: on March 21, 2014, the NASDAQ Biotechnology Index fell 10% sharply After this big fall, the biotechnology index, which has been popular for two years, has risen only 4% in total Investors are
